Capecitabine in Women With Operable Breast Cancer

Clinical trial NCT00148720 · TERMINATED

Trial details

NCT number: NCT00148720
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Invasive Breast Carcinoma Primary Invasive Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage III Breast Cancer

Start date: 2004-09-01
Primary completion: 2007-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.